|
National Stock Number(NSN): 6505-01-153-4284 (6505011534284, 011534284)
| NIIN: |
01-153-4284 |
Item Name: |
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS |
INC: |
34479
|
| FSC: |
6505
|
Assignment Date: |
May-15-1983 |
CRIT: |
N |
IIG: |
34479 |
| ISC: |
5 |
Date Standardized: |
Mar-12-1984 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Feb-01-2001 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
3-2432 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC42987-0111-15 |
26282
|
SYNTEX LABORATORIES INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NORINYL |
26282
|
SYNTEX LABORATORIES INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NORINYL 1/35 |
26282
|
SYNTEX LABORATORIES INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NORINYL TABLETS |
26282
|
SYNTEX LABORATORIES INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
Z |
Q |
U |
1 |
A |
$9.48 |
PG |
|
C2201X- |
Oct-01-2000 |
H |
| DF |
S9M |
Y |
|
Q |
U |
1 |
F |
$9.48 |
PG |
|
------- |
Oct-01-2000 |
H |
| DM |
S9M |
Y |
Z |
Q |
U |
1 |
M |
$9.48 |
PG |
|
13M2--1 |
Oct-01-2000 |
H |
| DN |
S9M |
Y |
|
Q |
U |
1 |
N |
$9.48 |
PG |
|
9L----- |
Oct-01-2000 |
H |
| DS |
S9M |
Y |
|
Q |
U |
1 |
D |
$9.48 |
PG |
|
------- |
Oct-01-2000 |
H |
| GP |
S9M |
Y |
|
Q |
U |
1 |
C |
$9.48 |
PG |
|
------- |
Oct-01-2000 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DM |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
35.000 MICROGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 1.000 MILLIGRAMS NORETHINDRONE ACETATE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
DISPENSER, PLASTIC COMPACT |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
21.000 TABLETS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
3 |
| FEAT |
SPECIAL FEATURES |
3 CYCLES; 21 TABLETS PER CYCLE |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUPP |
SUPPLEMENTARY FEATURES |
63 TABLETS IN A 3 CYCLE COMPACT OR 21 TABLETS IN A BLISTER TYPE RECTANGULAR PACKAGE |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-13-1996 |
3 |
H |
|
|
|
|
| C009 |
|
Jul-13-1996 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-13-1996 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-13-1996 |
3 |
H |
|
|
HD |
|
Replacement & Obsolete Information
| Obsolete NIIN Information |
|